Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

142.61 -3.40 (-2.33%)

Streaming Delayed Price Updated: 1:57 PM EDT, May 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying ↗

August 30, 2023

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 29, 2023

On Tuesday, 99 stocks hit new 52-week lows.

Via Benzinga

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany

August 28, 2023

From Insulet Corporation

Via Business Wire

What 8 Analyst Ratings Have To Say About Insulet ↗

August 10, 2023

Via Benzinga

Expert Ratings for Insulet ↗

May 30, 2023

Via Benzinga

Insulet Earnings Perspective: Return On Capital Employed ↗

May 17, 2023

Via Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know ↗

August 24, 2023

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 24, 2023

From Insulet Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗

August 21, 2023

Via Benzinga

NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday ↗

August 21, 2023

Credit Suisse lowered the price target for The Walt Disney Company (NYSE: DIS) from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to...

Via Benzinga

Recap: Insulet Q1 Earnings ↗

May 04, 2023

Via Benzinga

4 Analysts Have This to Say About Insulet ↗

April 17, 2023

Via Benzinga

Analyst Expectations for Insulet's Future ↗

February 24, 2023

Via Benzinga

JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth ↗

August 17, 2023

J.P.

Via Benzinga

Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)

August 08, 2023

From Insulet Corporation

Via Business Wire

Where to Invest $5,000 for the Next 20 Years ↗

August 02, 2023

These are high-growth opportunities investors should focus on for the long haul.

Via The Motley Fool

Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens ↗

July 05, 2023

This elite eight meet long-term growth criteria for sales and earnings.

Via Investor's Business Daily

Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023

July 05, 2023

From Insulet Corporation

Via Business Wire

Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers ↗

July 03, 2023

Via Benzinga

Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions

June 22, 2023

From Insulet Corporation

Via Business Wire

Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom

June 20, 2023

From Insulet Corporation

Via Business Wire

Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst ↗

May 26, 2023

Via Benzinga

AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near Buy Points ↗

May 06, 2023

AMD and a new S&P 500 member lead this weekend's watch list.

Via Investor's Business Daily

Insulet Reports Better-Than-Expected Q1 Earnings As Omnipod 5 Launch Gains Momentum, Lifts Guidance ↗

May 05, 2023

Via Benzinga

Insulet Announces New Organizational Structure to Drive Further Growth

May 04, 2023

From Insulet Corporation

Via Business Wire

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)

May 04, 2023

From Insulet Corporation

Via Business Wire

Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment

May 02, 2023

From Insulet Corporation

Via Business Wire

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

April 25, 2023

From Insulet Corporation

Via Business Wire

5 S&P 500 Stocks Showing Strength As Recession Fears Rise ↗

April 07, 2023

Medical stocks are holding up amid economic and market uncertainty.

Via Investor's Business Daily

Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023

March 30, 2023

From Insulet Corporation

Via Business Wire

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.